UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR February 2014


 Feb. 07, 2014
FirstFridays @OIP-ISR
 Theme:  "UCLA-Branded Mobile App Development"

 Feb. 27, 2014
OIP Patent Strategy Session
 Topic:  "Protecting Gene-Based and Diagnostic Inventions"

More Events


Dear Colleagues

This month we are pleased to release our report on OIP-ISR activities for fiscal years 2012 and 2013. We are proud to celebrate the ongoing successes of our inventors and licensees in developing new products and services based on UCLA innovation, which have culminated in bringing a number of new UCLA technologies to market.

In addition, three members of our office will be representing UCLA in workshops and on panels at the upcoming annual meeting of the Association of University Technology Managers in San Francisco later this month. I will be leading a discussion on “Optimizing Your Patent Budget,” Chief Operating Officer Ragan Robertson will be running an advanced course for administrative professionals, and Assistant Director Karla Zepeda will be a panelist in a discussion entitled, “Has AIA Changed the Way Universities Pursue Industry Collaboration?”

In addition, we have a number of exciting events coming up on campus, including OIP-ISR’s 2nd Annual Medical Device Partnering Conference on March 11th.

We look forward to seeing you on campus!


Brendan Rauw
Associate Vice Chancellor and Executive Director of Entrepreneurship
UCLA Office of Intellectual Property & Industry Sponsored Research


OIP-ISR Publishes UCLA Technology Transfer Report

Report features startup, technology licensing and industry collaboration developments at UCLA during the 2012 and 2013 fiscal years. New programs to enhance entrepreneurship and industry partnerships at UCLA are included.

ScaleFunder, Inc. Acquired by RuffaloCODY

RuffaloCODY announced last month the acquisition of startup, ScaleFunder Inc. Founded in 2012, ScaleFunder was launched to commercialize crowdfunding technology developed at UCLA.

CytoVale, Inc. Secures Seed Funding, SBIR Grant
SF-based, CytoVale, Inc. recently received $350,000 in seed funding from Peter Thiel's Breakout Labs program, and $650,000 in SBIR grants. CytoVale is commercializing microfluidics technology developed at UCLA.

OIP-ISR Hosts 2nd Annual Medical Device Partnering Conference at UCLA 
The 2nd Annual Medical Device Partnering Conference (by invitation only) provides a unique opportunity for UCLA inventors, investors, and industry executives to establish new relationships for furthering innovation.

 Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,637,470 - Small humanin-like peptides | P. Cohen, et al.
  • 8,634,677 - PACS optimization techniques | X. Hu, et al.
  • 8,624,357 - Composite semiconductor substrates for thin-film device layer . . . | M. Goorsky, et al.
  • 8,624,032 - Compound libraries made through phosphine-catalyzed annulation . . .  | O. Kwon, et al.
  • 8,617,798 - Customized lithographic particles | T. Mason, et al.
  • 8,617,557 - Antibody fusion with IL-12 proteins with disrupted heparin-binding . . .  | M. Penichet, et al.


New UCLA Technologies Available for Licensing



'Roundup:  Startup Funding and UCLA IP Licensing Highlights
UCLA Invents Newsletter, Vol. 2, No. 6

Subscribe and receive UCLA Invents by email: 

Send editorial comments and corrections to:  
Bob Nidever, Editor,  bnidever@research.ucla.edu

Contributors: Neil Bajpayee, Ben Dibling

UCLA Invents is published by the Office of Intellectual Property & Industry Sponsored Research
11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

Copyright 2014 UC Regents

Share this